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ABSTRACT
The galls of Quercus infectoria (QI) have been reported to possess numerous medicinal values and give a positive 
effect on bone metabolism. This study investigated the effects of semi-purified fractions of QI gall extract on 
the proliferation, alkaline phosphatase (ALP) activity, and mineralisation of human foetal osteoblast cell line (hFOB 
1.19). The semi-purified fractions (fraction A and B) were prepared by column chromatography methods. MTT assay 
was used to measure cell proliferation activity to obtain half maximal concentration (EC50) of the cells treated with 
fraction A (phenolic components and contained amide), fraction B (phenolic components with the presence of alkene), 
and pamidronate (drug control). The most potent or lowest EC50 was further used to measure ALP activity in the treated 
and untreated cells at day 1, 3, 7, 10, and 14 by ELISA. Cell mineralisation was determined by von Kossa staining for 
phosphate depositions and Alizarin Red S staining for calcium depositions. The EC50 values for fraction A and B were 
8.86 and 9.92 μg/mL, respectively, which showed a greater effect compared to the pamidronate (15.27 μg/mL). The ALP 
activity of both fractions in the treated cells were also greater compared to the two control groups (cells treated with 
pamidronate and untreated cells), starting from day 3 onwards. The calcium depositions appeared as red spots, while 
phosphate depositions appeared as black spots. Interestingly, the calcium depositions of cells treated with both fractions 
were higher than those of the two control groups. In conclusion, semi-purified fractions of QI gall extract enhanced 
proliferation, improved mineralisation, and increased ALP activity of hFOB 1.19 cells.
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ABSTRAK
Puru Quercus infectoria (QI) telah dilaporkan mempunyai nilai perubatan yang banyak dan memberi kesan positif 
pada metabolisme tulang. Penyelidikan ini dijalankan untuk mengkaji kesan fraksi separa tulen QI pada proliferasi, 
aktiviti alkalin fosfatase (ALP) dan pemineralan sel osteoblas fetal manusia (hFOB 1.19). Fraksi separa tulen QI (fraksi 
A dan B) telah disediakan melalui kaedah kromatografi kolum. Asai MTT digunakan untuk mengukur aktiviti proliferasi 
sel bagi menentukan kepekatan separa maksimum (EC50) sel yang dirawat dengan fraksi A (komponen fenolik dan 
mengandungi amida), fraksi B (komponen fenolik dengan kehadiran alkena) dan pamidronat. Nilai EC50 paling poten 
atau rendah yang diperoleh digunakan untuk mengukur aktiviti ALP dalam sel yang dirawat dan juga sel yang tidak 
dirawat pada hari 1, 3, 7, 10 dan 14 melalui ujian ELISA. Pemineralan sel ditentukan dengan pewarnaan von Kossa 
bagi pemendapan fosfat dan pewarnaan Alizarin Red S bagi pemendapan kalsium. Nilai EC50 bagi sel yang dirawat 
dengan fraksi A fraksi B masing-masing adalah 8.86 dan 9.92 μg/mL yang menunjukkan kesan lebih hebat berbanding 
pamidronat (15.27 μg/mL). Kedua-dua fraksi juga menunjukkan aktiviti ALP yang lebih tinggi berbanding kedua-dua 
kumpulan kawalan (sel yang dirawat dengan pamidronat dan sel yang tidak dirawat), bermula pada hari ke-3 dan 
hari-hari berikutnya. Pemendapan kalsium kelihatan sebagai tompokan merah manakala pemendapan fosfat kelihatan 
tompokan hitam. Menariknya, pemendapan kalsium oleh sel yang dirawat dengan kedua-dua fraksi adalah lebih tinggi 
berbanding dua kumpulan kawalan. Kesimpulannya, fraksi separa tulen QI menambahkan proliferasi, memperbaiki 
pemineralan dan meningkatkan aktiviti ALP sel hFOB 1.19. 
Kata kunci: Alizarin Red S; alkalin fosfatase (ALP); Quercus infectoria; sel hFOB 1.19; von Kossa
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INTRODUCTION
Osteoporosis is a skeletal disorder characterised by 
progressive loss of normal bone density with deterioration 
of bone microarchitecture. Osteoporosis increases the 
risk of fracture in a patient, which may become a major 
public health problem that is associated with age-related 
fractures (Sözen et al. 2017). In recent years, available 
treatments for osteoporosis have been designed to reduce 
bone loss or stimulate bone formation. 
Types of osteoporosis treatment include dietary 
and lifestyle changes and pharmacological intervention. 
Examples of effective treatments that have been proven 
to cure osteoporosis are bisphosphonates, calcitonin, 
and selective oestrogen receptor modulators (SERMs) 
(Davidson 2003). However, long-term usage of those 
treatment modalities can induce adverse effects in most 
patients. For instance, hormone replacement therapy (HRT) 
has been shown to increase the risk of ovarian and breast 
cancer in patients (Humphries & Sabrina Gill 2003; 
Zhou et al. 2008). This risk can become life-threatening 
if not managed properly.
Alternative medicine has become an option due to the 
long-term side effects caused by synthetic drug or modern 
medicine, although the advantages of modern medicine 
in curing health problems far exceed the disadvantages. 
Herbal remedies such as St. John’s wort, Ginkgo biloba, 
Echinacea, garlic, saw palmetto, ginseng, goldenseal, 
aloe, Siberian ginseng, and valerian have been used among 
Americans for health maintenance (Mar & Bent 1999). 
In Malaysia, Quercus infectoria (QI) or locally known as 
‘manjakani’ is one of the popular herbs used traditionally 
in postpartum care to restore the elasticity of the uterine 
wall (Muhamad & Mustafa 1994). 
 The main phytochemicals found in QI galls are 
polyphenols such as tannin (50 to 70%), gallic acid (2 to 
4%), and ellagic acid (Bruneton 1999). Polyphenols are 
a group of natural compounds with phenolic structural 
features and are strong antioxidants. Past studies have 
shown that different polyphenol subgroups may differ 
significantly in their stability, bioavailability, and effect 
on physiological functions (Tsao 2010). As reviewed 
by Habauzit and Horcajada (2008), polyphenols can 
affect bone metabolism. Osteoblast proliferation, 
differentiation, and mineralisation as well as osteoclast 
function may be modulated by polyphenols (Trzeciakiewicz 
et al. 2009).
Studies on modulation of cell function by polyphenols 
have been performed in different in vitro models such as 
cancer cells, epithelial cells, and skeletal cells (Fantini 
et al. 2015; Hurst et al. 2010; Noe et al. 2004; O’Prey et 
al. 2003; Vittal et al. 2004). Nevertheless, little is known 
regarding human osteoblastic cells. Bu et al. (2009) 
studied the influence of dried plum polyphenol extract 
on mouse calvarial preosteoblastic cells (MC3T3-E1) 
under normal and inflammatory conditions. They found 
that this extract was nontoxic for osteoblasts and was 
able to stimulate alkaline phosphatase (ALP) activity and 
mineralised nodule formation. Bone-specific ALP activity 
is associated with the bone formation rate in metabolic 
disease of the bone and during normal physiological 
bone growth (Gundberg 1993). In addition, Vester et al. 
(2014) showed that the incubation of human primary 
osteoblasts with green tea extract (containing more than 
80% polyphenols) significantly reduced oxidative stress 
and improved cell viability. In our previous study, the 
combination of osteoporotic drug (pamidronate) and 
semi-purified fractions of QI (QIsmF) with EC50 of 11.60 
µg/mL showed positive effects on the proliferation and 
differentiation of osteoblasts (Raudhah et al. 2018).
The aqueous crude extract of QI enhanced cell 
proliferation and increased bone formation markers 
(ALP and osteocalcin) (Hapidin et al. 2015). However, 
as QI extracts contain a combination of numerous types 
of bioactive compounds or phytochemicals (Sasidharan 
et al. 2011), it is difficult to determine which specific 
compounds or fractions of the extract that produce the most 
potent effects towards osteoblasts. Hence, in this study, 
the semi-purified polyphenol fractions of QI gall extract 
were obtained via chromatography techniques. Then, the 
effects of the selected semi-purified fractions (fraction A 
and B) on the proliferative activity were measured using 
enzyme-linked immunosorbent assay (ELISA), as well 
as mineralisation of a human foetal osteoblast cell line 
(hFOB 1.19 cells), which was observed using an inverted 
microscope and histochemical staining.
MATERIALS AND METHODS
PREPARATION OF Quercus infectoria GALLS EXTRACT
Quercus infectoria (QI) galls were bought from a Chinese 
traditional medicine store in Kota Bharu, Kelantan. The 
galls were identified based on their morphology such 
as external colour, size, surface, texture, odour, taste, 
and thickness (Asif et al. 2012). The plant identification 
was then certified by Assoc. Prof. Dr. Hasmah Abdullah, 
an experienced plant researcher at the School of 
Health Sciences, Universiti Sains Malaysia (USM). The 
specimen (QI012012) was deposited in the Biomedicine 
Laboratory, School of Health Sciences, USM.
QI gall extract was prepared according to our 
previous procedures, with some modifications (Hapidin 
et al. 2015). QI galls were crushed by using a pestle and 
mortar into small pieces, then ground into powder form 
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using an electronic grinder. QI powder was then extracted 
using distilled water by refluxing at 50 °C for 24 h. After 
that, the extract obtained was filtered using a Whatman 
No. 1 filter paper (GE Healthcare, UK) and concentrated 
by using a rotary evaporator (Heidolph Rotavac, Germany). 
The aqueous QI gall extract was further lyophilised in a 
freeze drier until powdery in form and stored at -20 °C 
for future usage.
PRODUCTION OF SEMI-PURIFIED Quercus infectoria 
POLYPHENOLS BY USING COLUMN CHROMATOGRAPHY
Flash column chromatography was performed on silica 
gel 60, 0.063-0.200 mm, 60 Å pore size, pH 6.5-7.5 in 
glass columns sized 40 mm in width and 500 mm in 
length. Silica gel was supplied by Merck, Millipore. Flash 
columns were manually packed using a layer of cotton 
plug and the slurry method. Cotton plug was transferred 
into the column for retention of adsorbent, followed by 
a transfer of 150 g silica gel in mobile phase solvents; 
acetonitrile:methanol:water (75:25:5). The sample was 
loaded with a Pasteur pipette directly to the head of the 
column before elution by dissolving 5 g of QI in 50 mL of 
70% ethanol. The mobile phase solvent was continuously 
added as the final layer simultaneously with the elution 
process until fraction collection was accomplished. The 
fractions were collected in test tubes, graduated with the 
fraction volume, and visualised by spotting on thin layer 
chromatography (TLC) plates. The fractions collected were 
labelled fraction A and fraction B.
FOURIER-TRANSFORM INFRARED SPECTROSCOPY (FTIR) 
ANALYSIS OF FRACTION A AND B
Fourier-transform infrared spectroscopy (FTIR) is 
a reliable and sensitive method for detection and 
identification of functional groups present in both 
fractions (Eberhardt et al. 2007; Hazra et al. 2007). In 
addition, it is widely used because of its simplicity, cost 
effectiveness, and rapidness in detecting phytocomponents 
(Aysal et al. 2007; Ibrahim & Abd-El-Aal 2008; Lieber 
et al. 1999). The efficiencies of herbal medicines depend 
on the amounts of active components, which could vary 
significantly in their contents. 
 Fractions A and B were scanned in the wavelength 
range of 600-5000 nm using Bruker Tensor 27 
Spectrophotometer (USA). FTIR analysis was performed 
using OPUS data collection program, which was used 
to detect the characteristic peaks and record the values 
of FTIR. Each analysis was repeated twice for spectrum 
confirmation. The FTIR spectrum was used to identify the 
functional groups of the active components based on the 
peak value in the region of infrared radiation.
CELL CULTURE
Cell Revival and Subculture
Human foetal osteoblast cell line hFOB 1.19 (CRL-11372) 
was purchased from ATCC (American Type Cell Culture) 
(Manassas, VA 20110, USA). The hFOB 1.19 cells at 
passage 16 was cultured in Dulbecco’s Modified Eagle 
Medium F-12 nutrient mixture (DMEM/F12) (Invitrogen 
GmBH, Karlsruhe, Germany), which was supplemented 
with 10% foetal bovine serum (FBS) (Invitrogen GmBH, 
Karlsruhe, Germany) and 1% penicillin/streptomycin 
serum (Invitrogen GmBH, Karlsruhe, Germany) 
(standard medium). The cells were incubated in 5% CO2 
37 °C humidified incubator (Sheldon, US) and monitored 
closely for 24 h. All procedures were carried out in an 
aseptic condition. 
Cell Treatment
Fraction A and B were diluted in dimethyl sulfoxide 
(DMSO) (Nacalai Tesque, Japan). Pamidronate (Toronto 
Research Chemicals, Canada) was used as a control drug, 
whereas the cells treated only with complete medium 
were used as the negative control. The treated cells were 
incubated for 72 h in the 37 °C humidified incubator 
supplemented with 5% CO2. The tests were conducted in 
triplicate and repeated for three independent times. All 
culturing work was handled using sterile techniques and 
done in Biosafety Cabinet Class II.
CELL VIABILITY AND HALF MAXIMAL EFFECTIVE 
CONCENTRATION (EC50) DETERMINATION
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-
tetrazolium bromide (MTT) assay (Nacalai Tesque, 
Japan) was performed to determine cell viability. Cell 
culture with more than 80% confluency was used and, in 
this test, yellow MTT was reduced to a purple formazan. 
MTT (5 mg) was measured using an electronic weighing 
balance and completely dissolved in 1 mL of Dulbecco’s 
Phosphate-Buffered Saline (PBS) (ThermoFisher 
Scientific, USA). Then, 15 µL of freshly prepared MTT 
dye (Nacalai Tesque, Japan) was added to each well, and 
the mixture was further incubated for 4 h (Putnam et al. 
2007).
After the supernatant was removed, 100 μL DMSO 
was added to all wells to solubilise the formazan crystals 
formed, and the plate was further incubated for 15 min. 
Then, absorbance (A) was measured at 570 nm using a 
microplate reader (Tecan Infinite M200, Switzerland) 
(Hassan et al. 2015). The intensity of the wavelength 
absorbed was proportional to the percentage of viable 
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cells present in the wells. The percentage of viable cells 
was calculated by using the following formula:
Percentage of viable cells = (OD Sample) / (OD Control) 
× 100%
where OD Sample is the optical density of treated samples; 
OD Control is the optical density of the control.
PROLIFERATION ASSAY
The proliferation assay was done to determine the number 
of hFOB 1.19 cells treated with pamidronate, fraction A 
and B at days 1, 3, 7, 10, and 14. The cells were plated at 
5×103 cells/well with a 100 uL culture medium per well 
in a 96-well microtiter plate and left overnight prior to 
attachment. Pamidronate, fraction A, and fraction B were 
added into each well at different concentrations, and the 
plate was incubated at 5% CO2 in a 37 °C humidified 
incubator. The cells were trypsinised with 100 uL trypsin/
EDTA and incubated for 3 min for the cells to detach. 
Then, an inverted microscope was used to view the cells 
and confirm that 90% detachment had occurred. To stop 
the trypsinisation process, 200 uL of culture medium was 
added, and the mixture was resuspended. Automated cell 
counting was carried out using Countess Automated Cell 
Counter (Invitrogen, USA), and the number of viable cells 
versus time for each treatment and control groups were 
plotted in a dose-response curve and analysed.
QUANTIFICATION OF ALP ACTIVITY IN MEDIUM BY 
ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
The alkaline phosphatase (ALP) activity of hFOB 1.19 
treated with fraction A, fraction B, and pamidronate 
was detected through the hydrolysis of p-nitrophenyl 
phosphate (substrate) into p-nitrophenol at 37 °C with 
pH 10.3. This was achieved by using the ALP ELISA 
test kit (Randox, UK). The cells were plated in a 96-well 
microtiter plate at 5×103 cells/well with 115 µL of culture 
medium per well. After 24 h, the cells were treated with 
the QI gall extract fractions and pamidronate. Then, the 
treated cells were incubated for 1, 3, 7, 10, and 14 days in 
37 °C humidified incubator supplemented with 5% CO2. 
ALP activity was measured using the ELISA plate reader 
(VersaMax, US) at 405 nm. 
HISTOCHEMICAL ASSAYS FOR MINERALISED CALCIUM 
PHOSPHATE DEPOSITS
Calcium staining
The fixed cultures were covered with 1.0% Alizarin Red 
S sodium solution (0.028% in NH4OH) (Sigma-Aldrich, 
USA), pH 4.2 for 20 min for calcium staining. The 
cultures were then rinsed with distilled water and acid 
ethanol (ethanol, 0.01% HCl) (McGee-Russell 1958). The 
calcium deposits were stained red and observed under an 
image analyser (Olympus, Japan).
Phosphate staining
von Kossa (Merck Millipore, USA) staining (McGee-
Russell 1958) was used for phosphate deposit assessment. 
The fixed cultures were covered with 1.0% silver nitrate 
solution (Merck Millipore, USA) and kept for 1 h under 
UV light. After rinsing, 5.0% sodium thiosulphate (Merck 
Millipore, USA) was added for 30 min, and the culture 
was washed again. Phosphate deposits were stained black 
and the cultures were observed under an image analyser 
(Olympus, Japan).
STATISTICAL ANALYSIS
Results were expressed as mean ± standard deviation 
(SD) of three independent experiments (n=3). Data for 
cell viability and EC50 determination were analysed with 
a one-way ANOVA test by using the GraphPad Prism 6.0. 
In addition, data analyses for the results of proliferation 
activity and ALP activity were performed using the IBM 
Statistical Package of Social Sciences (SPSS) software, 
version 22. Shapiro-Wilk test was used for normality. The 
statistical significance of differences was determined 
using one-way ANOVA followed by Tukey HSD test as a 
post-hoc. The results were considered to be statistically 
significant for a p value of < 0.05.
RESULTS AND DISCUSSION
FTIR SPECTROSCOPIC ANALYSIS OF FRACTION A AND 
FRACTION B
In this study, semi-purified fractions of QI gall extract were 
obtained through separation by column chromatography 
for polyphenol extraction and removal of unwanted 
compounds. The semi-purified fraction is the crude 
extracts that have typically undergone further generic 
processing using solid phase extraction as a chemical filter 
to bias the screening profile (Avery et al. 2010). Figures 
1 and 2 show the FTIR spectra for fraction A and B of QI 
gall extract, respectively. With reference to previous studies 
(Anand & Gokulakrishnan 2012; Vignesh et al. 2015; 
Yamunadevi et al. 2012), the results of FTIR peak values 
and different functional groups in both fraction A and B 
are shown in Table 1. Twenty different functional groups 
were analysed, and the wavelengths ranged from 600 to 
3800 cm−1. The commonly present functional groups 
in both fractions were alcohol or phenolic components, 
carboxylic acids, alkanes, and aromatic and alkyl halides. 
Fraction B showed the presence of alkene, but this 
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was absent in fraction A. On the other hand, fraction A 
contained amide or amines; however, this was not found 
in fraction B (Table 1). According to the peak values 
obtained from FTIR spectra of both fractions, the broad 
band at 3000-3700 cm−1 belongs to the stretching vibration 
of a phenolic hydroxyl group (–OH), which represents 
hydrogen bonding (Anand & Gokulakrishnan 2012; Naz 
et al. 2014; Pantoja-Castro & Gonzalez-Rodriguez 2012). 
Hence, both fractions of QI were found to contain the 
functional group of total phenolic content expressed mainly 
as tannin and gallic acid, ranging from 3300-3650 cm–1.  
FIGURE 1. FTIR Spectrum profile of fraction A
Wavenumbers cm-1
Wavenumbers cm-1
FIGURE 2. FTIR Spectrum profile of fraction B
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HALF MAXIMAL EFFECTIVE CONCENTRATION (EC50) 
OF Quercus infectoria SEMI-PURIFIED POLYPHENOLS AND 
PAMIDRONATE TREATMENTS FOR hFOB 1.19 CELLS
The EC50 value for fraction A was 8.86 and 9.62 µg/mL 
for fraction B, whereas EC50 for pamidronate was 15.27 
µg/mL (Figure 3). The fraction A and B of QI galls were 
more effective compared to pamidronate, since their EC50 
values were lesser. This indicates that a lower concentration 
of semi-purified fractions of QI gall extract is required to 
enhance the proliferation of hFOB 1.19 cells compared to 
pamidronate, the control drug.
TABLE 1. FTIR peak values and different functional groups in fraction A and B
Peak value (cm-1) Functional groups




















608-763 607-786 Alkyl halide
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PROLIFERATION ASSAY OF HFOB 1.19 CELLS
The EC50 values were then used in the treatment of hFOB 
1.19 cells to observe the pattern of cell proliferation 
during 14 days of incubation. The graph of proliferation 
versus time shows that the hFOB 1.19 cell count in all 
four groups significantly increased with time (day 3 until 
day 14). Interestingly, from day 3 onwards, the numbers 
of hFOB 1.19 cells treated with both fractions were 
significantly higher compared to those from the other two 
control groups. In addition, starting on day 7 onwards, the 
hFOB 1.19 cells treated with fraction B were significantly 
higher in number compared to those treated with fraction A 
(Figure 4). Thus, fraction B was much greater in enhancing 
proliferation activity of hFOB 1.19 cells compared to 
fraction A. 
FIGURE 3. Cell viability of hFOB 1.19 treated with pamidronate and semi-
purified fractions of QI (fraction A and B). EC50 values were calculated by 
using dose response stimulation curve in GraphPad Prism version 6.0 for 
Windows. The EC50 for fraction A was 8.86 μg/mL and fraction B was 9.62 
μg/mL; both were lower than EC50 for pamidronate, 15.27 μg/mL
FIGURE 4. Cell number (× 104) after 1, 3, 7, 10, and 14 days of incubation. The 
values of the bars represented the mean ± standard deviation (SD) of the four 
independent experiments. *Significant differences were detected between the four 
groups within the same day (p < 0.05) by one-way ANOVA and Tukey’s test. Days 
that shared the same letter showed a significant difference (within the same group) 
(p < 0.05) by one-way ANOVA and Tukey’s test
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ALKALINE PHOSPHATASE (ALP) ACTIVITY OF HFOB 1.19 
CELLS
The alkaline phosphatase (ALP) activities of hFOB 
1.19 cells in all four groups significantly increased with 
time, starting from day 3 until day 14. Figure 5 shows 
that from day 3 onwards, the ALP activities of hFOB 
1.19 cells treated with both fractions were significantly 
higher compared to those from the other two control 
groups. However, fraction B treatment resulted in a more 
significant and higher ALP activity compared to fraction 
A treatment, starting on day 3 onwards. Moreover, on 
day 14, the ALP activity of hFOB 1.19 cells treated with 
semi-purified fractions of QI extract was the highest, 
especially for fraction B, compared to the ALP activities 
for the control cells and cells treated with pamidronate 
(Figure 5).
FIGURE 5. ALP activity of hFOB 1.19 cells; untreated cells (control), cells-
treated pamidronate, and cells-treated with semi-purified polyphenols of QI 
(Fractions A and B) after 1, 3, 7, 10, and 14 days of incubation. The values of 
the bars represented the mean ± standard deviation (SD) of the four independent 
experiments. *Indicates significant difference between the four groups within the 
same day (p < 0.05) by one-way ANOVA and Tukey’s test. Days that shared the 
same letter showed a significant difference (within the same group) (p < 0.05) by 
one-way ANOVA and Tukey’s test
The increment of ALP activity during 14 days for 
all treatment groups proves the capability of all treatment 
vehicles, especially fractions A and B. The results 
obtained are consistent with a previous study where 
the ALP activity in hFOB/plasmid vector control cells 
significantly increased as a function of time in the cells 
and peaked on day 12 (Li et al. 2006). Furthermore, 
ALP was upregulated and increased in the presence of 
semi-purified fractions of QI extract (fractions A and 
B) just after 24 h and continued to increase twofold on 
day 7 of incubation. This condition is consistent with 
a previous study on pomegranate extract (PME) which 
possesses phenolic compounds, together with flavonoids, 
anthocyanins, and tannins, as the main group of 
antioxidant phytochemicals. The study found that PME 
(80 μg/mL) significantly increased the ALP activity of 
MC3T3-E1 osteoblast, supporting its suggested role in 
modulating osteoblastic cell differentiation (Sreekumar 
et al. 2014).
The ALP activities between both groups treated with 
semi-purified fractions of QI extract were also measured 
and compared. The upregulated activity of ALP might 
be induced by the presence of multifunctional groups 
in the fractions as shown by the FTIR spectra. Thus, the 
higher expression of ALP activity stimulated by fraction 
B is probably due to the presence of different types of 
functional groups of certain polyphenol compounds (e.g. 
carboxylic acid, alkene, and phenol group), which are 
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FORMATION OF MINERALISED CALCIUM AND 
PHOSPHATE DEPOSITS (HISTOCHEMICAL ASSAYS)
Calcium deposition appeared as red-orange spots when 
viewed under the inverted microscope. Figure 6(A) - 6(P) 
shows that the hFOB 1.19 cells treated with both fractions 
have a greater intensity of Alizarin Red S staining 
compared to cells treated with pamidronate starting from 
day 3 of incubation period until day 10. Interestingly, 
hFOB 1.19 cells treated with fraction B had the greatest 
intensity of calcium deposition at day 14 compared to the 
other three groups (Figure 6(Q) - 6(T)).
Besides that, phosphate deposition was identified by 
the presence of black spots from von Kossa staining when 
viewed under the inverted microscope. Starting from day 1 
until day 14, the amount of phosphate deposition increased 
in the cells treated with both semi-purified fractions of QI 
extract compared to the cells treated with pamidronate and 
untreated cells (Figure 7(A) - 7(T)).
more effective towards osteoblastic activity. Idris et al. 
(2009) concluded that biphenyl carboxylic acid derivatives 
like ABD350 have no significant inhibitory effects on 
osteoblast activity in vitro. Besides, phenols that contain 
carboxylic acid will form phenolic acid. Phenolic acids 
are the second largest subclass of polyphenols (Stipanuk & 
Caudill 2013). Many studies have found that polyphenols 
demonstrate a positive effect on bone metabolism. As 
such, a polyphenolic phytoestrogen enhances proliferation 
and osteoblastic differentiation in human bone marrow-
derived mesenchymal stem cell (hBMSC) cultures via 
ER-dependent mechanism and coupling to extracellular 
signal-regulated kinase 1/2 (ERK1/2) activation (Dai et al. 
2007). A study by Kowalczyk et al. (2012) concluded that 
five novel alkene-bridged analogues showed promising 
biological activity in a proliferation study in primary foetal 
rat osteoblasts at physiological concentrations. Besides, 
Garcia-Martinez et al. (2016) found that phenolic 
compounds and extracts from different varieties of extra 
virgin olive oil stimulate human osteoblast cell (MG-63) 
proliferation. 
FIGURE 6. hFOB 1.19 cells after stained with Alizarin Red S (calcium deposition) from day 1 until day 14, 
viewed at 20× magnification using an image analyser. (A) Day 1, untreated hFOB 1.19 cells, (B) Day 1, hFOB 
1.19 cells treated with pamidronate, (C) Day 1, hFOB 1.19 cells treated with Fraction A, (D) Day 1, hFOB 1.19 
cells treated with Fraction B, (E) Day 3, untreated hFOB 1.19 cells, (F) Day 3, hFOB 1.19 cells treated with 
pamidronate, (G) Day 3, hFOB 1.19 cells treated with Fraction A, (H) Day 3, hFOB 1.19 cells treated with 
Fraction B, (I) Day 7, untreated hFOB 1.19 cells, (J) Day 7, hFOB 1.19 cells treated with pamidronate, (K) Day 
7, hFOB 1.19 cells treated with Fraction A, (L) Day 7, hFOB 1.19 cells treated with Fraction B, (M) Day 10, 
untreated hFOB 1.19 cells, (N) Day 10, hFOB 1.19 cells treated with pamidronate, (O) Day 10, hFOB 1.19 cells 
treated with Fraction A, (P) Day 10, hFOB 1.19 cells treated with Fraction B, (Q) Day 14, untreated hFOB 
1.19 cells, (R) Day 14, hFOB 1.19 cells treated with pamidronate, (S) Day 14, hFOB 1.19 cells treated with 
Fraction A, (T) Day 14, hFOB 1.19 cells treated with Fraction B
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In this study, mineral deposition staining per viable 
hFOB 1.19 cells treated with fraction A and B increased 
at day 14, in a time-dependent manner. This condition is 
in accordance with a previous study (Tong et al. 2007). 
Human embryonic stem cells (hESCs) formed bone 
nodules when co-cultured with human bone marrow 
mesenchymal stem cell (hBMSCs) that have differentiated 
for 14 days. The bone nodules stained positively for von 
Kossa and Alizarin Red S. Mineralised nodule formation 
is the hallmark of in vitro osteogenic differentiation. In 
contrast, cells grown with undifferentiated hBMSCs only 
showed minimal level of mineral deposition and weak 
staining (Tong et al. 2007). 
Greater Alizarin Red S and von Kossa staining 
indicate higher levels of mineral depositions (Tong et al. 
2007). Therefore, semi-purified fractions of QI extract 
enhanced the mineralisation in hFOB 1.19 cells more 
effectively compared to pamidronate due to their high 
amount of calcium and phosphate deposition. In addition, 
formation of mineralised calcium and phosphate deposits 
FIGURE 7.  hFOB 1.19 cells stained with von Kossa (phosphate deposition) from day 1 until day 
14, viewed at 22× magnification using an inverted microscope. (A) Day 1, untreated hFOB 1.19 
cells, (B) Day 1, hFOB 1.19 cells treated with pamidronate, (C) Day 1, hFOB 1.19 cells treated 
with Fraction A, (D) Day 1, hFOB 1.19 cells treated with Fraction B, (E) Day 3, untreated hFOB 
1.19 cells, (F) Day 3, hFOB 1.19 cells treated with pamidronate, (G) Day 3, hFOB 1.19 cells 
treated with Fraction A, (H) Day 3, hFOB 1.19 cells treated with Fraction B, (I) Day 7, untreated 
hFOB 1.19 cells, (J) Day 7, hFOB 1.19 cells treated with pamidronate, (K) Day 7, hFOB 1.19 cells 
treated with Fraction A, (L) Day 7, hFOB 1.19 cells treated with Fraction B, (M) Day 10, untreated 
hFOB 1.19 cells, (N) Day 10, hFOB 1.19 cells treated with pamidronate, (O) Day 10, hFOB 1.19 
cells treated with Fraction A, (P) Day 10, hFOB 1.19 cells treated with Fraction B, (Q) Day 14, 
untreated hFOB 1.19 cells, (R) Day 14, hFOB 1.19 cells treated with pamidronate, (S) Day 14, 
hFOB 1.19 cells treated with Fraction A, (T) Day 14, hFOB 1.19 cells treated with Fraction B
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in both cells treated with semi-purified fractions of QI 
extract were also observed and compared. Treatment with 
fraction B resulted in greater Alizarin Red S content, 
which indicates higher levels of mineral calcium compared 
to cells treated with fraction A.
von Kossa and Alizarin Red S staining are widely 
used to detect calcification in skeletal tissues, and they 
are the standard methods to visualise mineralisation in 
osteogenic cell cultures (Bonewald et al. 2003). The von 
Kossa method is based on the binding of silver ions to the 
anions (phosphates, sulphates, or carbonates) of calcium 
salts and the reduction of silver salts to form dark brown 
or black metallic silver staining. Contrasting the non-
specificity of von Kossa for calcium, Alizarin Red S reacts 
with calcium cation to form a chelate (Wang et al. 2006). 
Some pitfalls in von Kossa might be the reason we were 
unable to see the difference of mineral phosphate contents 
between the cells treated with fraction A and fraction B. 
To overcome the limitations of conventional histological 
von Kossa and Alizarin Red S stain techniques as well 
as enable live analyses, fluorochrome-based labelling 
methods, such as Giemsa staining, have been proposed for 
the evaluation of bonelike nodule mineralisation in vitro 
(Querido et al. 2012). 
The result of ALP activity is congruent with 
mineralisation activity. The ALP activity of cells treated 
with the fractions increased in a time-dependent manner; 
likewise, the mineral depositions were also augmented. 
This shows that there is a connection between ALP levels 
and mineral contents. To support this, a previous study had 
shown that resveratrol, a natural polyphenolic compound 
(3,5,4′-trihydroxy-trans-stilbene) present in fruits 
positively affected the bone, primarily by stimulating 
formation or mineralisation (Ornstrup et al. 2014). 
Next, Domazetovic et al. (2020) found that blueberry 
polyphenols protect from oxidative damage factors 
related to bone remodelling and bone formation, such as 
ALP and Runt-related transcription factor 2 (Runx2), and 
improve long-term activation of the mineralisation process 
in human osteoblast-like (SaOS-2) cells.
CONCLUSION
In conclusion, osteoblasts (hFOB 1.19 cells) treated 
with semi-purified fractions of QI extract were better in 
proliferation, ALP activity, and mineralisation compared 
to cells treated with pamidronate. Both semi-purified 
fractions (fractions A and B) enhanced bone metabolism 
with only a small effective concentration compared to 
pamidronate. Furthermore, the semi-purified fractions of 
QI extract also increased cell proliferation by increasing 
the level of bone formation markers (ALP) secreted by 
osteoblast cells. Moreover, the semi-purified fractions of 
QI extract also improved the mineralisation activity where 
they enhanced calcium and phosphate deposits of hFOB 
1.19 cells. 
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